The WACC of Silence Therapeutics PLC (SLN.L) is 7.3%.
| Range | Selected | |
| Cost of equity | 5.90% - 8.70% | 7.30% |
| Tax rate | 12.70% - 16.00% | 14.35% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.9% - 8.6% | 7.3% |
| Category | Low | High |
| Long-term bond rate | 2.9% | 3.4% |
| Equity market risk premium | 5.3% | 6.3% |
| Adjusted beta | 0.56 | 0.74 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.90% | 8.70% |
| Tax rate | 12.70% | 16.00% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.9% | 8.6% |
| Selected WACC | 7.3% | |